22.418 articles found

Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment.

Blandini F, Cosentino M, Mangiagalli A, Marino F, Samuele A, Rasini E, Fancellu R, Tassorelli C, Pacchetti C, Martignoni E, Riboldazzi G, Calandrella D, Lecchini S, Frigo G, Nappi G.

J Neural Transm (Vienna) · 2004-03-19

DOI: 10.1007/s00702-004-0123-1PMID: 15254790

MODULATORS OF THE G PROTEIN-COUPLED FORMYL PEPTIDE RECEPTOR-LIKE 2 AND THEIR THERAPEUTIC USE AGAINST CELL DEATH-RELATED DISORDERS

VILLEGAS Sonia, KELNER Gregory, UNETT David, GATLIN Joel.

· 2004-03-15

Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Cell Death-Related Disorders

VILLEGAS SONIA, KELNER GREGORY S, UNETT DAVID J, GATLIN JOEL.

· 2004-03-15

MODULATORS OF THE G PROTEIN-COUPLED FORMYL PEPTIDE RECEPTOR-LIKE 2 AND THEIR THERAPEUTIC USE AGAINST CELL DEATH-RELATED DISORDERS

KELNER GREGORY, VILLEGAS SONIA, GATLIN JOEL, UNETT DAVID J.

· 2004-03-15

Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Cell Death-Related Disorders

VILLEGAS SONIA, KELNER GREGORY S, UNETT DAVID J, GATLIN JOEL.

· 2004-03-15

Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders

BARTOSZYK GERD, BOTTCHER HENNING, SEYFRIED CHRISTOPH, RUSS HERMANN, BOKEL HEINZ-HERMANN, SCHMID-GROBMANN USCHI.

· 2004-03-11

NOVEL USE OF SUBSTITUTED AMINOMETHYL CHROMANS FOR THE TREATMENT OF MOVEMENT DISORDERS AND OF ADVERSE EFFECTS INDUCED BY DRUGS ADMINISTERED TO TREAT EXTRAPYRAMIDAL MOVEMENT DISORDERS.

CHRISTOPH SEYFRIED.

· 2004-03-10

Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases

MUELLER ALAN L, MOE SCOTT T.

· 2004-03-09

Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases

MUELLER ALAN L, MOE SCOTT T.

· 2004-03-09

COMBINATION TREATMENT FOR IMPAIRED MOTOR FUNCTION IN PARKINSON'S DISEASE

VERGEZ JUAN A, LANIER ALAN B, FELEDER ETHEL C, MEYER GLENN A, RICCI MARCELO A, FAOUR JOAQUINA.

· 2004-03-05

METHODS OF USING AND COMPOSITIONS COMPRISING SELECTIVE CYTOKINE INHIBITORY DRUGS FOR THE TREATMENT AND MANAGEMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM

SCHAFER Peter H..

· 2004-03-05

Gene therapy for Parkinson's disease.

Lawlor PA, During MJ.

Expert Rev Mol Med · 2004-03-02

DOI: 10.1017/s146239940400746xPMID: 15000692